Side-by-side comparison of AI visibility scores, market position, and capabilities
Mumbai smartphone-based diagnostic platform with color-change test cards for UTI, diabetes, and kidney tests for 4K+ doctors; YC S21 $2.48M Omidyar Network-backed with Cipla/Sun Pharma/AstraZeneca partnerships for India at-home diagnostics.
Neodocs is a Mumbai, India-based healthtech company — backed by Y Combinator (S21) with $2.48 million raised including a $2 million seed round in February 2024 led by Omidyar Network India with YC, 9Unicorns, Gemba Capital, Titan Capital, and 100Unicorns — providing instant at-home diagnostic test kits with proprietary biochemistry test cards that deliver visual color-change results for conditions including urinary tract infections, diabetes monitoring (HbA1c and glucose), kidney function (creatinine, protein), and general wellness panels without requiring any additional hardware beyond a smartphone camera. Founded in 2020, Neodocs has sold 200,000+ test cards used by 4,000+ doctors across India and has partnerships with major pharmaceutical companies including Cipla, Sun Pharma, and AstraZeneca for co-branded diagnostic test distribution.
Largest API marketplace with 4M developers and thousands of API providers; unified discovery, testing, and management for public and enterprise internal APIs.
RapidAPI is the world's largest API marketplace and developer hub, providing a platform where developers discover, connect to, and manage thousands of public and private APIs through a unified interface. Founded in 2015 and headquartered in San Francisco, RapidAPI connects over 4 million developers with APIs from thousands of providers — weather data, financial data, social media, translation, geolocation, and every category of web service — through a single authentication layer and consistent SDK.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.